Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
AIM ImmunoTech Inc. stock logo
AIM
AIM ImmunoTech
$0.43
+5.3%
$0.43
$0.32
$0.75
$21.73M-0.1211,516 shs82,219 shs
SPDR Bloomberg Barclays Intermediate Term Treasury ETF stock logo
ITE
SPDR Bloomberg Barclays Intermediate Term Treasury ETF
$27.50
-0.2%
$28.64
$31.06
$63.21
$412.50MN/A482,468 shs1.04 million shs
Adams Natural Resources Fund, Inc. stock logo
PEO
Adams Natural Resources Fund
$23.42
-0.9%
$22.58
$19.22
$24.25
$597.44M1.2234,954 shs41,166 shs
Rosetta Stone Inc. stock logo
RST
Rosetta Stone
$29.99
$29.98
$8.85
$31.24
$737.78M0.78492,413 shsN/A
7 AI Stocks to Invest In: An Introduction to AI Investing For Self-Directed Investors Cover

As the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
AIM ImmunoTech Inc. stock logo
AIM
AIM ImmunoTech
-5.47%-13.16%-7.61%+0.87%-17.81%
SPDR Bloomberg Barclays Intermediate Term Treasury ETF stock logo
ITE
SPDR Bloomberg Barclays Intermediate Term Treasury ETF
-0.22%-0.11%-2.31%-3.00%-5.73%
Adams Natural Resources Fund, Inc. stock logo
PEO
Adams Natural Resources Fund
+0.42%+2.03%+4.19%+14.99%+14.88%
Rosetta Stone Inc. stock logo
RST
Rosetta Stone
0.00%0.00%0.00%0.00%0.00%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
AIM ImmunoTech Inc. stock logo
AIM
AIM ImmunoTech
N/AN/AN/AN/AN/AN/AN/AN/A
SPDR Bloomberg Barclays Intermediate Term Treasury ETF stock logo
ITE
SPDR Bloomberg Barclays Intermediate Term Treasury ETF
N/AN/AN/AN/AN/AN/AN/AN/A
Adams Natural Resources Fund, Inc. stock logo
PEO
Adams Natural Resources Fund
N/AN/AN/AN/AN/AN/AN/AN/A
Rosetta Stone Inc. stock logo
RST
Rosetta Stone
N/AN/AN/AN/AN/AN/AN/AN/A

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
AIM ImmunoTech Inc. stock logo
AIM
AIM ImmunoTech
N/AN/AN/AN/A
SPDR Bloomberg Barclays Intermediate Term Treasury ETF stock logo
ITE
SPDR Bloomberg Barclays Intermediate Term Treasury ETF
0.00
N/AN/AN/A
Adams Natural Resources Fund, Inc. stock logo
PEO
Adams Natural Resources Fund
N/AN/AN/AN/A
Rosetta Stone Inc. stock logo
RST
Rosetta Stone
N/AN/AN/AN/A

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
AIM ImmunoTech Inc. stock logo
AIM
AIM ImmunoTech
$200K108.66N/AN/A$0.20 per share2.14
SPDR Bloomberg Barclays Intermediate Term Treasury ETF stock logo
ITE
SPDR Bloomberg Barclays Intermediate Term Treasury ETF
N/AN/AN/AN/AN/AN/A
Adams Natural Resources Fund, Inc. stock logo
PEO
Adams Natural Resources Fund
N/AN/AN/AN/AN/AN/A
Rosetta Stone Inc. stock logo
RST
Rosetta Stone
$182.70M4.04$0.10 per share313.52($0.67) per share-44.76

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
AIM ImmunoTech Inc. stock logo
AIM
AIM ImmunoTech
-$28.96M-$0.60N/AN/A-14,337.62%-121.69%-97.91%5/13/2024 (Estimated)
SPDR Bloomberg Barclays Intermediate Term Treasury ETF stock logo
ITE
SPDR Bloomberg Barclays Intermediate Term Treasury ETF
N/AN/A0.00N/AN/AN/AN/AN/A
Adams Natural Resources Fund, Inc. stock logo
PEO
Adams Natural Resources Fund
N/AN/A0.00N/AN/AN/AN/AN/A
Rosetta Stone Inc. stock logo
RST
Rosetta Stone
-$12.96M-$0.55N/AN/AN/A-10.28%N/A-9.91%N/A

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
AIM ImmunoTech Inc. stock logo
AIM
AIM ImmunoTech
N/AN/AN/AN/AN/A
SPDR Bloomberg Barclays Intermediate Term Treasury ETF stock logo
ITE
SPDR Bloomberg Barclays Intermediate Term Treasury ETF
$1.324.80%N/AN/AN/A
Adams Natural Resources Fund, Inc. stock logo
PEO
Adams Natural Resources Fund
$1.355.76%+14.20%N/AN/A
Rosetta Stone Inc. stock logo
RST
Rosetta Stone
N/AN/AN/AN/AN/A

Latest RST, PEO, AIM, and ITE Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
4/18/2024
Adams Natural Resources Fund, Inc. stock logo
PEO
Adams Natural Resources Fund
Quarterly$0.101.71%5/16/20245/17/20245/31/2024
(Data available from 1/1/2013 forward)

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
AIM ImmunoTech Inc. stock logo
AIM
AIM ImmunoTech
N/A
1.68
1.68
SPDR Bloomberg Barclays Intermediate Term Treasury ETF stock logo
ITE
SPDR Bloomberg Barclays Intermediate Term Treasury ETF
N/AN/AN/A
Adams Natural Resources Fund, Inc. stock logo
PEO
Adams Natural Resources Fund
N/AN/AN/A
Rosetta Stone Inc. stock logo
RST
Rosetta Stone
N/A
0.53
0.52

Ownership

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
AIM ImmunoTech Inc. stock logo
AIM
AIM ImmunoTech
2650.75 million50.74 millionNot Optionable
SPDR Bloomberg Barclays Intermediate Term Treasury ETF stock logo
ITE
SPDR Bloomberg Barclays Intermediate Term Treasury ETF
N/A15.00 millionN/ANot Optionable
Adams Natural Resources Fund, Inc. stock logo
PEO
Adams Natural Resources Fund
N/A25.51 million25.50 millionOptionable
Rosetta Stone Inc. stock logo
RST
Rosetta Stone
74624.60 millionN/AOptionable

RST, PEO, AIM, and ITE Headlines

SourceHeadline
Rosetta Stone Promo Code - Up to 50% offRosetta Stone Promo Code - Up to 50% off
glamourmagazine.co.uk - April 24 at 9:35 PM
Rosetta Stone for Schools and Lynn Public Schools Partner to Accelerate Equitable Language LearningRosetta Stone for Schools and Lynn Public Schools Partner to Accelerate Equitable Language Learning
tmcnet.com - April 16 at 8:56 AM
Get an Extra 20% Off Rosetta Stone & StackSkillsGet an Extra 20% Off Rosetta Stone & StackSkills
msn.com - April 11 at 4:17 PM
Rosetta Stone has 25 languages to learn and you have a lifetime to do itRosetta Stone has 25 languages to learn and you have a lifetime to do it
msn.com - April 11 at 4:17 PM
This lifetime e-learning bundle, ft. Rosetta Stone, is now available at an even lower priceThis lifetime e-learning bundle, ft. Rosetta Stone, is now available at an even lower price
popsci.com - April 10 at 12:41 PM
Expand International Communication with Lifetime Access to Rosetta Stone Language LearningExpand International Communication with Lifetime Access to Rosetta Stone Language Learning
msn.com - April 7 at 8:56 PM
Opinion – Bill Straub: Immigration emerges as GOP’s ‘Rosetta Stone’ to reclaiming White HouseOpinion – Bill Straub: Immigration emerges as GOP’s ‘Rosetta Stone’ to reclaiming White House
nkytribune.com - April 5 at 12:50 AM
Learn multiple languages with a lifetime subscription Rosetta StoneLearn multiple languages with a lifetime subscription Rosetta Stone
msn.com - April 3 at 4:21 PM
Scotch Tape scotch, Rosetta Stone for stoners and more April Fools brand gagsScotch Tape scotch, Rosetta Stone for stoners and more April Fools' brand gags
wbal.com - April 1 at 3:00 PM
Why this obscure comic is the Rosetta Stone of The MatrixWhy this obscure comic is the Rosetta Stone of The Matrix
dexerto.com - March 31 at 3:55 AM
Deals: Rosetta Stone Lifetime Subscription to Learn Spanish save 59%Deals: Rosetta Stone Lifetime Subscription to Learn Spanish save 59%
geeky-gadgets.com - March 26 at 9:19 AM
5 Best Duolingo Alternatives to Boost your Language Skills5 Best Duolingo Alternatives to Boost your Language Skills
insidermonkey.com - March 23 at 6:40 PM
Sign up for a lifetime of Rosetta Stone for more than half offSign up for a lifetime of Rosetta Stone for more than half off
popsci.com - March 23 at 9:36 AM
A lifetime subscription to Rosetta Stone is on sale for 52% offA lifetime subscription to Rosetta Stone is on sale for 52% off
mashable.com - March 20 at 5:42 PM
Scientists Discover “Molecular Rosetta Stone” – Findings Reveal How Our Microbiome Talks to UsScientists Discover “Molecular Rosetta Stone” – Findings Reveal How Our Microbiome Talks to Us
scitechdaily.com - March 20 at 5:42 PM
Learn a New Language With a Lifetime of Rosetta StoneLearn a New Language With a Lifetime of Rosetta Stone
msn.com - March 18 at 1:27 PM
Songs for the soul— Sister Rosetta TharpeSongs for the soul— Sister Rosetta Tharpe
themtnear.com - March 15 at 3:11 PM
Learn 24 languages with Rosetta Stones $179.99-lifetime dealLearn 24 languages with Rosetta Stone's $179.99-lifetime deal
msn.com - March 12 at 1:50 PM
Molecular Rosetta Stone reveals how our microbiome talks to us'Molecular Rosetta Stone' reveals how our microbiome talks to us
sciencedaily.com - March 12 at 1:36 AM
“Molecular Rosetta Stone” Reveals How our Microbiome Talks to Us“Molecular Rosetta Stone” Reveals How our Microbiome Talks to Us
today.ucsd.edu - March 11 at 3:35 PM
Molecular Rosetta Stone reveals how our microbiomes talk to us'Molecular Rosetta Stone' reveals how our microbiomes 'talk' to us
msn.com - March 11 at 3:35 PM
Get Rosetta Stone and StackSkills Unlimited for nearly $700 offGet Rosetta Stone and StackSkills Unlimited for nearly $700 off
msn.com - March 10 at 12:04 PM
Save an extra 20% on Rosetta Stone and StackSkills Unlimited and enrich your mind for lifeSave an extra 20% on Rosetta Stone and StackSkills Unlimited and enrich your mind for life
msn.com - March 10 at 7:03 AM
Learn 24 languages: Get 50% off lifetime access to Rosetta StoneLearn 24 languages: Get 50% off lifetime access to Rosetta Stone
yahoo.com - March 8 at 12:32 PM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

All Headlines

Company Descriptions

AIM ImmunoTech logo

AIM ImmunoTech

NYSE:AIM
AIM ImmunoTech Inc., an immuno-pharma company, focuses on the research and development of therapeutics to treat multiple types of cancers, viral diseases, and immune-deficiency disorders in the United States. The company's lead product candidate is Ampligen, a drug of macromolecular ribonucleic acid molecules for the treatment of chronic fatigue syndrome (CFS). It is also developing Ampligen for the treatment of renal cell carcinoma, malignant melanoma, non-small cell lung, ovarian, breast, colorectal, prostate and pancreatic cancer, myalgic encephalomyelitis, Hepatitis B, HIV, COVID-19, and post-COVID conditions. In addition, the company provides Alferon N Injection, an injectable formulation of natural alpha interferon to treat human papilloma viruses, and genital warts, a sexually transmitted disease. AIM ImmunoTech Inc. has agreements with Amarex Clinical Research LLC; Pharmaceutics International Inc.; Polysciences Inc.; and University of Cagliari Dipartimento di Scienze della Vita e dell'Ambiente. The company was formerly known as Hemispherx Biopharma, Inc. and changed its name to AIM ImmunoTech Inc. in August 2019. AIM ImmunoTech Inc. was incorporated in 1966 and is headquartered in Ocala, Florida.
SPDR Bloomberg Barclays Intermediate Term Treasury ETF logo

SPDR Bloomberg Barclays Intermediate Term Treasury ETF

NYSEARCA:ITE
Adams Natural Resources Fund logo

Adams Natural Resources Fund

NYSE:PEO
Adams Natural Resources Fund, Inc. is a publicly owned investment manager. The firm invests in the public equity markets across the globe. The firm manages closed-end equity fund focused on the energy and material sectors. It invests in stocks of companies of all market capitalizations operating in the energy and natural resources sector including oil companies, exploration and production, utilities, services, and basic materials sectors. The firm employs a fundamental analysis with a bottom-up stock picking approach while focusing on earnings growth prospects, defendable market position, market competition, macroeconomic backdrop, cash flow generation, valuation, capital allocation, return on capital, mileposts and catalysts, and point in cycle identification to make its investments. It benchmarks the performance of its portfolios against a composite index of 80% Dow Jones Oil and Gas Index and 20% Dow Jones Basic Materials Index. The firm was formerly known as Petroleum & Resources Corporation. Adams Natural Resources Fund, Inc. was founded in 1929 and is based in Baltimore, Maryland with an additional office in Boston, Massachusetts.
Rosetta Stone logo

Rosetta Stone

NYSE:RST
Rosetta Stone Inc., together with its subsidiaries, provides technology-based learning products in the United States and internationally. It operates through three segments: Literacy, E&E Language, and Consumer Language. The company develops, markets, and supports a suite of language-learning and literacy solutions consisting of web-based software subscriptions, online and professional services, and mobile applications, as well as practice applications. It also provides administrative tools for performance monitoring, and measure and track learner progress; professional services; and custom solutions, including curriculum development, global collaboration programs, group and live tutoring, and language courses for mission-critical government programs. The company offers its products under the Rosetta Stone, The Blue Stone Logo, Lexia, Lexia PowerUP Literacy, and TruAccent trademarks. It sells its products and services through call centers, websites, app-stores, third party e-commerce websites, retail resellers, consignment distributors, daily deal partners, home shopping resellers, and third-party resellers and distributors, as well as directly to individuals, educational institutions, corporations, and government agencies. Rosetta Stone Inc. was founded in 1992 and is headquartered in Arlington, Virginia.